The benefit – risk report for COVID-19 vaccine from AstraZeneca remains unmodified; the benefits of vaccinating exceeding the risks presented by adverse effects, specified on Thursday evening, the National Committee for Coordinating Activities against COVID-19 (CNCAV), mentioning one of the conclusions of the committee for evaluating the risk in matter of pharmacovigilance within the European […] The post CNCAV, after decision of European Agency of Medicine on AstraZeneca vaccine: We encourage reporting of all adverse reactions first appeared on Ziarul Profit.
